Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02223247 |
| Title | A Phase 1, First-In-Human Study of Escalating Doses of Oral TVB-2640 in Patients With Solid Tumors |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | 3V Biosciences, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | GBR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Scottsdale | Arizona | 85258 | United States | Details | ||
| Denver | Colorado | 80218 | United States | Details | ||
| Sarasota | Florida | 34232 | United States | Details | ||
| Oklahoma City | Oklahoma | 73104 | United States | Details | ||
| Nashville | Tennessee | 37203 | United States | Details | ||
| Dallas | Texas | 75390 | United States | Details | ||
| San Antonio | Texas | 78229 | United States | Details | ||
| Charthouse Square, London | United Kingdom | Details | ||||
| London | W1G 6AD | United Kingdom | Details | |||
| Manchester | United Kingdom | Details | ||||
| West Smithfield, London | United Kingdom | Details |